Maj Invest Equity logo

Maj Invest Equity

Europe, Hovedstaden, Denmark, Copenhagen

Description

Maj Invest is one of Denmark’s leading asset management companies.

Investor Profile

Maj Invest Equity has made 20 investments, with 4 in the past 12 months and 35% as lead.

Stage Focus

  • Series Unknown (35%)
  • Series C (20%)
  • Series B (10%)
  • Series E (10%)
  • Series A (10%)
  • Private Equity (5%)
  • Series D (5%)
  • Seed (5%)

Country Focus

  • India (65%)
  • Denmark (15%)
  • Indonesia (10%)
  • Norway (5%)
  • Israel (5%)

Industry Focus

  • Financial Services
  • Finance
  • Banking
  • Fintech
  • Lending
  • Biotechnology
  • Payments
  • Life Science
  • Micro Lending
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Maj Invest Equity frequently co-invest with?

Access Biotechnology
North America, New York, United States, New York
Co-Investments: 1
AV
North America, New York, United States, New York
Co-Investments: 1
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 2
Faering Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 2
Women's World Banking
North America, New York, United States, New York
Co-Investments: 1
Accion
North America, District of Columbia, United States, Washington
Co-Investments: 2
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Muthoot Finance
Asia, Kerala, India, Ernakulam
Co-Investments: 2
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Amicus Capital Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does Maj Invest Equity often collaborate with?

Sanjay Nayar
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
Yogesh Mahansaria
Asia, Maharashtra, India, Mumbai
Shared Deals: 1
HB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Shared Deals: 1

What are some of recent deals done by Maj Invest Equity?

Liva Healthcare

Copenhagen, Hovedstaden, Denmark

Liva Healthcare is a digital coaching platform that provides evidence-based coaching to manage and prevent chronic conditions.

AppsFitnessHealth CaremHealthSoftwareWellness
Series UnknownFeb 5, 2025
Finova Capital

Jaipur, Rajasthan, India

Finova Capital is a non-banking financial company that provides loans for micro and small businesses.

BankingFinanceFinancial Services
Series EOct 29, 2024
Amount Raised: $135,000,000
FlexiLoans

Mumbai, Maharashtra, India

FlexiLoans is a lending platform for SMEs to access quick, flexible, and adequate funds to grow their businesses.

BankingFinancial ServicesFinTechInformation TechnologyLendingPaymentsVenture Capital
Series CSep 10, 2024
Amount Raised: $34,531,102
Amartha

Jakarta, Jakarta Raya, Indonesia

Amartha is a microfinance technology platform that connects micro and SME business partners with investors.

Financial ServicesFinTechLendingMobile Apps
Series UnknownJun 18, 2024
Amount Raised: $17,500,000
Namdev Finvest

Jaipur, Rajasthan, India

Namdev Finvest operates a non-banking finance platform that provides loans to rural and semi-urban agriculture.

Electric VehicleEnergyFinanceFinancial Services
Series CApr 2, 2024
Amount Raised: $19,000,000
Save Solutions

Gaya, Bihar, India

A Financial services provided Company.

BankingFinancial Services
Series UnknownMar 1, 2024
Amount Raised: $3,000,000
Morrow Batteries

Oslo, Oslo, Norway

Morrow Batteries is to develop and manufacture the world’s most cost-effective and sustainable battery cells.

BatteryElectrical DistributionElectronicsManufacturing
Series UnknownSep 22, 2023
Amount Raised: $74,206,684
Protai

Tel Aviv, Tel Aviv, Israel

Protai is an AI-powered drug discovery startup.

Artificial Intelligence (AI)BiotechnologyLife Science
SeedMar 15, 2023
Amount Raised: $12,000,000
Hemab

Copenhagen, Hovedstaden, Denmark

Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

BiotechnologyLife SciencePharmaceutical
Series BFeb 21, 2023
Amount Raised: $135,000,000
Synklino

Lyngby, Hovedstaden, Denmark

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

BiotechnologyHealth Care
Series AJun 8, 2022
Amount Raised: $31,985,458